Purification and use of recombinant inhibitor of apoptosis proteins as caspase inhibitors.
Burnham Institute, La Jolla, California 92137, USA.
Q L
QL
Deveraux
K
K
Welsh
J C
JC
Reed
D000818:Animals; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology*; D053148:Caspase 3; D053179:Caspase 7; D061945:Caspase Inhibitors; D002846:Chromatography, Affinity / Q000379:methods; D002853:Chromatography, Liquid / Q000379:methods; D003001:Cloning, Molecular / Q000379:methods; D003574:Cytochrome c Group / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000302:isolation & purification* / Q000494:pharmacology; D004926:Escherichia coli; D005982:Glutathione Transferase / Q000302:isolation & purification; D007700:Kinetics; D011506:Proteins / Q000235:genetics / Q000302:isolation & purification* / Q000494:pharmacology*; D011993:Recombinant Fusion Proteins / Q000302:isolation & purification; D011994:Recombinant Proteins / Q000302:isolation & purification / Q000494:pharmacology; D051636:X-Linked Inhibitor of Apoptosis Protein
D061945:Caspase Inhibitors; D003574:Cytochrome c Group; D004791:Enzyme Inhibitors; D011506:Proteins; D011993:Recombinant Fusion Proteins; D011994:Recombinant Proteins; D051636:X-Linked Inhibitor of Apoptosis Protein; D005982:Glutathione Transferase; D053148:Caspase 3; D053179:Caspase 7